The Role of Amyloid-β, tau, andApolipoprotein Eε4 in Alzheimer Disease: How Is the Team Playing?

CSF T-Tau/Aβ42 Predicts White Matter Microstructure in Healthy Adults at Risk for Alzheimer’s Disease

(2012) Barbara B. Bendlin et al.   PLoS One

Amyloid-β associated volume loss occurs only in the presence of phospho-tau

(2011) Rahul S. Desikan et al.   ANNALS OF NEUROLOGY

Early and late onset Alzheimer's disease patients have distinct patterns of white matter damage

(2010) Elisa Canu et al.   NEUROBIOLOGY OF AGING

White Matter Damage in Alzheimer Disease and Its Relationship to Gray Matter Atrophy

(2010) Federica Agosta et al.   RADIOLOGY

Effect of APOE on biomarkers of amyloid load and neuronal pathology in AD

(2009) Prashanthi Vemuri et al.   ANNALS OF NEUROLOGY

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

Apolipoprotein E ε4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia

(2009) Federica Agosta et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA